Investors poured $61 million into a cannabis cultivation scheme that regulators say funded luxury cars instead of marijuana grow sites.
Management sees German medical market quadrupling as it awaits key EU certification and works to boost production capacity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback